Nitish says, Nobody can beat Modi in 2019; slams Congress

Agencies
August 1, 2017

Patna, Aug 1: Bihar chief minister Nitish Kumar on Monday tore into Rashtriya Janata Dal chief Lalu Prasad, insisting continuing in the Grand Alliance would have amounted to "compromising with corruption".

Having embraced the BJP after a four-year hiatus, Nitish claimed there would be "no challenge" to Prime Minister Narendra Modi in the 2019 general elections.

He also said the proposal for a reunion had come from the "highest level" in the BJP which he accepted as "going got impossible" in the Grand Alliance due to accusations of corruption against his then deputy Tejashwi Yadav.

"There were corruption charges and cases were filed by the CBI (against Lalu Prasad and family). I had only told them to come out with proper answers. Instead, they made fun of me saying whether I was a CBI official or the police," he told a press conference.

"Laluji did not give any clarification on corruption charges. How could I remain silent after having talked about zero tolerance to corruption? Now I have a feeling that they did not have a proper answer," Nitish said. Nitish, till recently seen as a potential challenger to Modi, said, "Nobody else (other than Modi) can occupy the PM's post. Now nobody has the strength to beat rpt beat Modi."

Asked about his future role in national politics, Nitish, also the JD(U) chief, said, "Ours is a small party which does not harbour big national aspirations." When asked about the possibility of JD(U) becoming part of NDA at the national level with ministers in the Modi government, Kumar said the JD(U) national executive will meet in Patna on August 19 and all such issues will be decided there.

He also hit back at RJD supremo Lalu Prasad and Congress vice president Rahul Gandhi for criticising him for forging an alliance with "communal" BJP.

"Making huge money hiding behind the shield of secularism ...is this secularism? ... I need no certificate of secularism from anybody," he said, questioning Lalu's secularist credentials.

Highlighting his own commitment to secularism, he said his government had given compensation to the victims of the Bhagalpur communal riots on par with those of the 1984 anti-Sikh riots.

On reports that senior JD(U) leader Sharad Yadav was upset over the party joining hands with BJP, he said, "It is not necessary that everybody always agrees on everything. One can have divergent views. The decision to break the Grand Alliance was taken by Bihar JD(U) at its executive meeting which I had to abide by." "JD(U) is registered with the Election Commission as a

regional party in Bihar and hence going against the decision of the state party was not possible for me," he said. Nitish mocked at Rahul Gandhi for claiming that he had an inkling that Kumar would walk out of the coalition for the last three to four months. "Then why did he (Gandhi) meet me when I had gone to Delhi and sought his intervention...to ask RJD to come clean on the accusations.

"Congress did not act on time in Assam also when AGP had come on board. It cost us the Assam polls," he said, adding "we can be a partner but not a camp follower." Even as Nitish defended his decision of aligning with the BJP, JD(U) veteran Sharad Yadav had earlier in the day voiced his disapproval, saying the mandate in the 2015 Assembly polls

was for the grand alliance. He termed the development "unpleasant" and "unfortunate".

"The situation is very unpleasant to us... It is unfortunate that the coalition has been broken. People's mandate was not for it. Bihar's 11 crore people had endorsed our alliance," Yadav told reporters outside Parliament.

The Rajya Sabha member has met a number of opposition leaders since Nitish walked out of the 3-party Grand Alliance, which also included the Congress, and joined the NDA camp.

In Lucknow, BJP chief Amit Shah dismissed allegations of his party engineering splits and defections in rival political organisations.

"In Bihar, we did not break any party. Nitish had tendered his resignation as he had decided that he will not put up with corruption. Should we have told him with a gun to his temple that stay in that alliance?," Shah told a press conference.

Nitish also slammed Lalu over his claim that he made him the chief minister despite RJD having more MLAs. "He (Lalu) arrogantly says that he made me the CM ... The people of Bihar showed him his worth in 2010 (when RJD's strength was reduced to 22)," he said. Meanwhile, in a boost to the fledgling JD(U)-NDA alliance dispensation in Bihar, the Patna High Court today dismissed two PILs challenging the formation of a new government by Nitish Kumar, saying the court's intervention was no longer required after the floor test in the state Assembly. While one public interest litigation was filed by RJD MLAs Saroj Yadav and Chandan Verma, the other was by Jitendra Kumar, a Samajwadi Party member.

Nitish had comfortably won the confidence vote 131-108 on Friday.

 

Comments

hotman
 - 
Tuesday, 1 Aug 2017

If Lalu's son has any complaint on corruption, then drop him and warn his father about the issue.

Why did resign and joined BJP which you have already divorced/left them from the earlier union.

 

Bihar people have not voted you to join BJP, you have cheated them.

Your commitment was with Lalu, you should have continued.

 

Biharis will not forget you.

 

AK
 - 
Tuesday, 1 Aug 2017

Cheaters alwz like the LIARS and the DECIEVERS...

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 23,2020

New Delhi, May 23: The nationwide lockdown will no longer help India in its fight against COVID-19, and in its place community-driven containment, isolation and quarantine strategies have to be brought into play, leading virologist Shahid Jameel said.

The recipient of Shanti Swarup Bhatnagar Prize for Science and Technology also stressed that testing should be carried out vigorously to identify coronavirus hotspots and isolate those areas.

"Our current testing rate at 1,744 tests per million population is one of the lowest in the world. We should deploy both antibody tests and confirmatory PCR tests. This will tell us about pockets of ongoing infection and past (recovered) infection. This will provide data to open up gradually and let economic activity resume," Jameel told PTI in an interview.

He stressed that testing has to be dynamic to continuously monitor red, orange and green zones and change these based on that data.

About community transmission of COVID-19 in India, Jameel said the country reached that stage long ago.

"We reached community transmission a long time ago. It's just that the health authorities are not admitting it. Even ICMR's own study of SARI (severe acute respiratory illness) showed that about 40 per cent of those who tested positive for SARS-CoV-2 did not have any history of overseas travel or contact to a known case. If this is not community transmission, then what is?" he posed.

Lockdown bought India time in its fight against coronavirus, but continuing it is unlikely to yield any further dividend, Jameel said.

"Instead, community-driven local lockdowns, isolations and quarantines have to come into play. Building trust is most important so that people follow rules. A public health problem cannot be dealt with as a law-and-order problem."

The nationwide lockdown, initially imposed from March 25 to April 14, has been extended thrice and will continue at least till May 31. The virus has claimed 3,720 lives and infected over 1.25 lakh people in the country so far.

Jameel has expertise in the fields of molecular biology, infectious diseases, and biotechnology. He is the CEO of Wellcome Trust/Department of Biotechnology's India Alliance and is best known for extensive research in Hepatitis E virus and HIV.

He said COVID-19 will eventually be controlled through herd immunity, which is acquired in two ways – when a sufficient fraction of the population gets infected and recovers, and with vaccination.

"It is estimated that for SARS-CoV-2 at least 60 per cent of the population would have to be infected and recovered, or vaccinated. This will happen over the course of the next few years," Jameel said.

Herd immunity is reached when the majority of a population becomes immune to an infectious disease, either because they have become infected and recovered, or through vaccination. When that happens, the disease is less likely to spread to people who aren't immune, because there just aren't enough infectious carriers.

"India has 1.38 billion people, a population density of about 400/sq km and a healthcare system ranked at 143 in the world. If we allow 60 per cent people to get infected quickly in the hopes of herd immunity, that would mean 830 million infections," Jameel said.

"If 15 per cent need hospitalization that means about 125 million isolation beds (we have 0.3 million). If five per cent need oxygen and ventilatory support, this amounts to about 42 million oxygen support and ICU beds; we have 0.1 million oxygen support beds and 34,000 ICU beds. This would overwhelm the healthcare system causing mayhem," he said.

Jameel said if the population level mortality is 0.5 per cent that would mean 40 lakh deaths. "Are we prepared to pay this price for herd immunity in the short term? Clearly not," he said.

He said it is unlikely that a vaccine would be available by the end of the year.

"Even then, we don't know yet how long it would give protection – weeks, months, one year, a few years? I don't think we will return to pre-coronavirus days for at least the next 3-5 years. This is also a chance to evaluate if we want to return to those unsustainable, environment-damaging ways. COVID-19 is a timely warning to reform our way of living," he said.

Jameel said it is hard to predict but plausible that COVID-19 would return in second or third wave.

"Later waves come when we don't understand the disease and become lax. A comparison to Spanish Flu is not entirely valid because in 1918 no one knew what caused it. No one had seen a virus till the mid-1930s as the electron microscope needed to view those was invented in 1931," he said.

"Today we know a lot more about the pathogen, its genetic makeup, how it transmits and how to prevent it. We need to be sensible and follow expert advice," he said.

If there is any scientific evidence linking deforestation, rapid urbanisation, climate change with pandemics like COVID-19, he said zoonotic viruses -- those that jump from animals to humans -- happen so when wild animal–human contacts increase.

"Deforestation destroys animal habitats bringing them closer to humans. When you cut forests, bats come to roost on trees closer to human habitations. Their viruses in secretions/stool get transmitted to domestic animals and on to humans. This happened clearly with Nipah virus outbreak in Malaysia in 1997-98 from fruit bats to pigs to humans," he said.

"COVID-19 possibly arose in wet animal markets due to dietary habits that bring all kinds of live and dead wild animals in close contact with humans," Jameel added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 27,2020

Hyderabad, Jun 27: Ahead nurse working with a state-run hospital here died on Friday while undergoing treatment for COVID-19, a hospital official said.

The nurse, who was due to retire this month-end, tested positive about 10 days ago, he said.

The woman, who had been on medical leave for about 20 days, is suspected to have contracted the virus when she attended a private function in a neighbouring district, he said.

She was treated at the hospital for two days after she was found positive for COVID-19.

However, she was shifted to another government hospital as the symptoms continued unabated and sugar levels were high, he said.

The woman, who had comorbidities like diabetes and hypertension, died today.

Meanwhile, about 20 healthcare personnel, including doctors and paramedical staff, have so far tested positive for COVID-19 at the state-run Gandhi hospital, according to a hospital official.

He also said that there are around 50 patients whose family members have not come forward to take them home though the patients can be in home quarantine.

Family members have cited reasons such as residents not allowing a positive patient to return to the villages and presence of children at residences, for not taking them home, he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.